Hyliion HYLN insider plans 9,039-share Rule 144 NYSE sale
Rhea-AI Filing Summary
Hyliion Holdings (HYLN) has a holder planning to sell restricted or control common shares under Rule 144. The notice covers the proposed sale of 9,039 common shares through UBS Financial Services Inc., with an aggregate market value of $15,000, to be sold on or about 11/17/2025 on the NYSE. The securities were acquired on 11/17/2025 as an employee benefit, with the purchase price paid in cash. The filing also notes that 175,974,228 common shares were outstanding, providing context for the size of the planned sale.
Positive
- None.
Negative
- None.
FAQ
What does the Hyliion Holdings (HYLN) Form 144 filing disclose?
The Form 144 discloses a planned sale of 9,039 Hyliion common shares under Rule 144, with an aggregate market value of $15,000, to be sold on or about 11/17/2025 on the NYSE.
How many Hyliion (HYLN) shares are involved in this Rule 144 sale?
The notice covers a proposed sale of 9,039 common shares of Hyliion Holdings.
What is the reported value of the Hyliion (HYLN) shares to be sold?
The aggregate market value of the Hyliion common shares covered by the notice is $15,000.
When are the Hyliion (HYLN) shares expected to be sold under this Form 144?
The approximate date of sale reported is 11/17/2025, with the shares to be sold on the NYSE.
How and when were the Hyliion (HYLN) shares being sold acquired?
The 9,039 common shares were acquired on 11/17/2025 as an employee benefit, with the purchase price paid in cash.
How many Hyliion (HYLN) common shares were outstanding according to the notice?
The Form 144 reports that 175,974,228 common shares of Hyliion were outstanding, giving a baseline for the size of the planned sale.
Which broker is handling the planned Hyliion (HYLN) share sale under Rule 144?
The planned sale of 9,039 Hyliion common shares is listed as being through UBS Financial Services Inc. in Weehawken, New Jersey.